Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease

Neuroscience Letters

Volumn 531, Issue 2, 2012, Pages 209-214

  Depboylu, Candan ^a   Höllerhage, Matthias ^a,b,c   Schnurrbusch, Stefan ^a   Brundin, Patrik ^d   Oertel, Wolfgang H ^a   Schrattenholz, André ^e   Höglinger, Günter U ^a,b,c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d LUND UNIVERSITY   (Sweden)

^e PROTEOSYS AG   (Germany)

Author keywords

Dopamine; ErbB4; Neuregulin; Neurodegeneration; Parkinson

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEUROMELANIN; OXIDOPAMINE;

AGED; ARTICLE; AUTOPSY; BRAIN STEM; BRAIN TISSUE; CADAVER; CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LUND HUMAN MESENCEPHALON; MALE; MESENCEPHALON; MITOSIS; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SUBSTANTIA NIGRA; TISSUE SECTION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CELLS, CULTURED; DOPAMINERGIC NEURONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; PARKINSON DISEASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; UP-REGULATION;

EID: 84870436503     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.10.050     Document Type: Article

References (31)

1. Abe Y., Namba H., Zheng Y., Nawa H. In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 2009, 161:95-110.
2. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. Journal of the Neurological Sciences 1973, 20:415-455.
3. Birchmeier C. ErbB receptors and the development of the nervous system. Experimental Cell Research 2009, 315:611-618.
4. Buonanno A., Fischbach G.D. Neuregulin and ErbB receptor signaling pathways in the nervous system. Current Opinion in Neurobiology 2001, 11:287-296.
5. Carlsson T., Schindler F.R., Höllerhage M., Depboylu C., Arias-Carrión O., Schnurrbusch S., Rösler T.W., Wozny W., Schwall G.P., Groebe K., Oertel W.H., Brundin P., Schrattenholz A., Höglinger G.U. Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease. Journal of Neurochemistry 2011, 117:1066-1074.
6. Chong V.Z., Thompson M., Beltaifa S., Webster M.J., Law A.J., Weickert C.S. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophrenia Research 2008, 100:270-280.
7. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
8. Depboylu C., Schäfer M.K., Arias-Carrión O., Oertel W.H., Weihe E., Höglinger G.U. Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. Journal of Neuropathology and Experimental Neurology 2011, 70:125-132.
9. Depboylu C., Weihe E., Eiden L.E. Lentiviral infection of rhesus macaques causes long-term injury to cortical and hippocampal projections of prostaglandin-expressing cholinergic basal forebrain neurons. Journal of Neuropathology and Experimental Neurology 2012, 71:15-27.
10. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology Neurosurgery Psychiatry 1988, 51:745-752.
11. Hemmerle A.M., Numan S., Lundgren K.H., Seroogy K.B. Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats. Neuroscience 2009, 163:482-489.
12. Hirsch E., Graybiel A.M., Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988, 334:345-348.
13. Iwakura Y., Piao Y.S., Mizuno M., Takei N., Kakita A., Takahashi H., Nawa H. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. Journal of Neurochemistry 2005, 93:974-983.
14. Jaaro-Peled H., Hayashi-Takagi A., Seshadri S., Kamiya A., Brandon N.J., Sawa A. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends in Neurosciences 2009, 32:485-495.
15. Kastin A.J., Akerstrom V., Pan W. Neuregulin-1-beta1 enters brain and spinal cord by receptor-mediated transport. Journal of Neurochemistry 2004, 88:965-970.
16. Kato T., Abe Y., Sotoyama H., Kakita A., Kominami R., Hirokawa S., Ozaki M., Takahashi H., Nawa H. Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. Molecular Psychiatry 2011, 16:307-320.
17. Kwon O.B., Paredes D., Gonzalez C.M., Neddens J., Hernandez L., Vullhorst D., Buonanno A. Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. Proceedings of the National Academy of Sciences United States of America 2008, 105:15587-15592.
18. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260:1130-1132.
19. Lotharius J., Falsig J., van Beek J., Payne S., Dringen R., Brundin P., Leist M. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. Journal of Neuroscience 2005, 25:6329-6342.
20. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nature Reviews Neuroscience 2008, 9:437-452.
21. Rösler T.W., Depboylu C., Arias-Carrión O., Wozny W., Carlsson T., Höllerhage M., Oertel W.H., Schrattenholz A., Höglinger G.U. Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1. Neuropharmacology 2011, 61:1413-1418.
22. Schwab S.G., Wildenauer D.B. Update on key previously proposed candidate genes for schizophrenia. Current Opinion in Psychiatry 2009, 22:147-153.
23. Steiner H., Blum M., Kitai S.T., Fedi P. Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Experimental Neurology 1999, 159:494-503.
24. Stonecypher M.S., Byer S.J., Grizzle W.E., Carroll S.L. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors. Oncogene 2005, 24:5589-5605.
25. Thoenen H., Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nature Neuroscience 2002, 5:1046-1050.
26. Thompson M., Lauderdale S., Webster M.J., Chong V.Z., McClintock B., Saunders R., Weickert C.S. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Research 2007, 113:95-109.
27. Thuret S., Alavian K.N., Gassmann M., Lloyd C.K., Smits S.M., Smidt M.P., Klein R., Dyck R.H., Simon H.H. The neuregulin receptor ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta. Journal of Neurochemistry 2004, 91:1302-1311.
28. Woo R.S., Lee J.H., Yu H.N., Song D.Y., Baik T.K. Expression of ErbB4 in the apoptotic neurons of Alzheimer's disease brain. Anatomy and Cell Biology 2010, 43:329-332.
29. Woo R.S., Lee J.H., Yu H.N., Song D.Y., Baik T.K. Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease. Anatomy and Cell Biology 2011, 44:116-127.
30. Zhang L., Fletcher-Turner A., Marchionni M.A., Apparsundaram S., Lundgren K.H., Yurek D.M., Seroogy K.B. Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures. Journal of Neurochemistry 2004, 91:1358-1368.
31. Zheng Y., Watakabe A., Takada M., Kakita A., Namba H., Takahashi H., Yamamori T., Nawa H. Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans. Progress in Neuro-psychopharmacology & Biological Psychiatry 2009, 33:701-706.